A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses

Published:2020-06 Issue:6 Volume:10 Page:1047-1060
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Zhai Wenjie,Zhou Xiuman,Wang Hongfei,Li Wanqiong,Chen Guanyu,Sui Xinghua,Li Guodong,Qi Yuanming,Gao Yanfeng

Funder

National Natural Science Foundation of China

Key Scientific Research Projects of Henan Higher Education Institutions

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference54 articles.

1. Cancer immunotherapy;Gravitz;Nature,2013

2. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

3. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

4. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med,2016

5. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma;Nghiem;N Engl J Med,2016

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges;Acta Pharmaceutica Sinica B;2024-09

2. Design and Biophysical Characterization of Second-Generation Cyclic Peptide LAG-3 Inhibitors for Cancer Immunotherapy;2024-08-06

3. Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma;Journal for ImmunoTherapy of Cancer;2024-07

4. ImmunoPET imaging of LAG-3 expression in tumor microenvironment with⁶⁸Ga-labelled cyclic peptides tracers: from bench to bedside;Journal for ImmunoTherapy of Cancer;2024-07

5. Immunomodulatory Peptides for Tumor Treatment;Advanced Healthcare Materials;2024-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3